Pharma News
-
ESC publishes new guidelines to manage diabetes and CCS
Pharma | News | 0 Comment | 10 Sep, 2019
The European Society of Cardiology (ESC) has published new clinical practice guidelines on the management of diabetes and ‘chronic coronary syndromes (CCS)’, which replace the 2...Read more
-
ASLAN’s to present abstract on Varlitinib at ESMO Asia congress 2019
Pharma | News | 0 Comment | 10 Sep, 2019
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused Biopharma Company, on 10 Sep 2019 announced that an abstract on its lead candidate, varlitinib, h...Read more
-
Kaspersky alerts on increasing pharmaceuticals cyber-crimes
Pharma | News | 0 Comment | 10 Sep, 2019
Global cybersecurity company Kaspersky reveals an alarming trend observed in the pharmaceutical industry – a year-on-year steady increase on the number of devices being attacked by cy...Read more
-
Pharma | Analysis | 0 Comment | 10 Sep, 2019
Celgene Corporation’s INREBIC (fedratinib) became the first drug to be approved by the U S Food and Drug Administration (FDA) in nearly a decade for the treatment of myelofibrosi...Read more
-
Quetiapine Fumarate ER gets drug registration approval by NMPA
Pharma | News | 0 Comment | 09 Sep, 2019
Sihuan Pharmaceutical Holdings Group Ltd. on 27 August 2019, announced that the Quetiapine Fumarate ER Tablet, an antipsychotic drug jointly developed with its subsidiary PharmaDax (FoShan)...Read more
-
Takeda issues US recall of NATPARA, a parathyroid hormone
Pharma | News | 0 Comment | 09 Sep, 2019
Takeda Pharmaceutical Company Limited, on 6 Sep 2019, announced that the company is issuing a US recall for all doses of NATPARA® (parathyroid hormone) for Injection (25 mcg, 50 mcg, 75...Read more
-
Eisai launches antimicrobial wet wipes
Pharma | News | 0 Comment | 09 Sep, 2019
Eisai Co., Ltd. has launched Etak® Antimicrobial Wet Wipes (classified as miscellaneous goods) containing long-acting antimicrobial agent Etak® at pharmacies and drugstore...Read more
-
Sumitomo Dainippon inks strategic collaboration with Roivant Sciences
Pharma | News | 0 Comment | 06 Sep, 2019
Sumitomo Dainippon Pharma Co., Ltd. , a leading Japanese pharmaceutical company, and Roivant Sciences Ltd., a technology-enabled healthcare company, have announced that they have entered in...Read more
-
EC approves Merck’s KEYTRUDA in combination with Inlyta to treat RCC
Pharma | News | 0 Comment | 05 Sep, 2019
Merck, known as MSD outside the United States and Canada,has announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with Inlyta (axiti...Read more
-
Schrödinger, AstraZeneca join hands to accelerate drug dicovery
Pharma | News | 0 Comment | 05 Sep, 2019
Schrödinger, scientific leader in developing state-of-the-art chemical simulation software, has announced a collaboration with AstraZeneca to deploy Schrödinger’s ...Read more
-
Eisai to develop cognitive function test with Cogstate
Pharma | News | 0 Comment | 05 Sep, 2019
Tokyo headquartered Eisai Co., Ltd. has announced that it has entered into a business alliance agreement for exclusive development and commercialization of a cognitive function test - Cogst...Read more
-
GVK BIO announces new appointment
Pharma | News | 0 Comment | 05 Sep, 2019
GVK BIO, a leading global Contract Research and Development Organisation (CRDO), has announced the promotion of Sudhir Kumar Singh, Ph.D., to the position of Chief Operating Officer and the...Read more
-
Sanofi evaluates impact and prevention of influenza at ‘Options X’
Pharma | News | 0 Comment | 05 Sep, 2019
Sanofi Pasteur, a world leader in influenza and paediatric vaccines, organised a symposium in Singapore on acute respiratory disease to demonstrate the public health impact of influenza and...Read more
-
Mundipharma, Cidara ink $568M deal for antifungal treatment
Pharma | News | 0 Comment | 04 Sep, 2019
Cidara Therapeutics, Inc. and Mundipharma have announced that they have entered into a strategic partnership to develop and commercialize rezafungin for the treatment and prevention of inva...Read more
-
Kyowa Kirin gets FDA nod for Parkinson’s drug
Pharma | News | 0 Comment | 03 Sep, 2019
Japan headquartered Kyowa Kirin has announced that the U.S. Food and Drug Administration (FDA) has granted approval for NOURIANZTM (istradefylline) for use as adjunctive treatment to levodo...Read more
-
ITM, DCB sign agreement for Targeted Radionuclide Therapy
Pharma | News | 0 Comment | 02 Sep, 2019
ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies, and DuChemBio Co, Ltd. (DCB), a leading Korean radiopharmaceutical company, anno...Read more
-
Clinigen to distribute Etopophos, Vepesid in Australia and NZ
Pharma | News | 0 Comment | 03 Sep, 2019
Clinigen Group plc, the global pharmaceutical and services company, and CHEPLAPHARM Arzneimittel GmbH (‘CHEPLAPHARM’), the family-owned pharmaceutical company based in Germany, ...Read more
-
anti-BCMA autologous CAR-T cells (CT053) receives US FDA orphan drug designation
Pharma | News | 0 Comment | 02 Sep, 2019
CARsgen Therapeutics Inc., a clinical-stage biopharmaceutical company, on 31 August 2019, announced the United States Food and Drug Administration (FDA) has granted orphan drug designation ...Read more
